Skip to main content
Premium Trial:

Request an Annual Quote

People in the News

Oxford Nanopore Technologies: Wendy Mira Becker, Timothy Cowper, and James Peter Willcocks

Oxford Nanopore Technologies has terminated Wendy Mira Becker, Timothy Cowper, and James Peter Willcocks as its directors, according to the company's public filings.

Genialis: Krista McKerracher

RNA biomarker company Genialis has appointed Krista McKerracher as chairperson of the board of directors. McKerracher has held senior commercial and R&D leadership roles at Johnson & Johnson and Novartis Oncology. She has also worked for CRISPR Therapeutics, where she led the team that brought HbF edited stem cells for hemoglobinopathies to the clinic. She graduated from the University of Waterloo with a BSc in applied health sciences, and holds an MBA from York University.

Ultima Genomics: Diane Lince

Ultima Genomics has hired Diane Lince as VP of global marketing. Prior to joining Ultima, Diane was VP of global marketing at NanoString Technologies and head of marketing at Element Biosciences. She also oversaw Illumina's benchtop NGS portfolio and was director of regional marketing for the Americas. She holds a doctorate in chemistry and biochemistry from Arizona State University.

Biocartis: Gina Wallar, Judith Vacchino

Molecular diagnostics firm Biocartis has appointed Gina Wallar as chief business officer and Judith Vacchino as VP of global marketing.

Wallar previously served as chief commercial officer at Flagship Biosciences. Prior to that, she was senior VP and general manager at Fulgent Genetics. She has also previously served as president of the pharma services division at NeoGenomics. Wallar holds a master's degree in epidemiology and biostatistics from Boston University and a PhD in cancer epidemiology from the University of California, Los Angeles.

Vacchino was previously senior director of product marketing at Grail. She also previously spent nearly 15 years at Genomic Health, where she helped drive the adoption of the Oncotype DX Breast Recurrence Score. After Genomic Health was acquired by Exact Sciences in 2019, Vacchino was appointed as senior director of HCP marketing for oncology and urology products at Exact. She holds a bachelor's degree in chemistry from Rutgers University and a PhD in biophysical chemistry from Stanford University.

IndyGeneUS: Kaakpema Yelpaala

IndyGeneUS has appointed Kaakpema Yelpaala as chair of its advisory board. Yelpaala is a senior fellow and lecturer at the Yale School of Public Health and serves as the faculty director for InnovateHealth Yale. He cofounded InOn Health, a company that uses digital innovations to improves healthcare access in the US by enhancing connectivity between multicultural populations and healthcare services. Prior to this, he was the founder of International.

Genetic Signatures: Allison Rossiter

Allison Rossiter has been appointed CEO of Australian molecular diagnostics firm Genetic Signatures. She takes over from Interim CEO Neil Gunn, who will remain with the company as non-executive director. The previous CEO, John Melki, stepped down in April. Rossiter most recently served as managing director of Roche Diagnostics' Australia business and she previously worked as the global lifecycle leader for molecular point-of-care products for US-based Roche Molecular Systems.

Illumina: Everett Cunningham

Illumina announced the appointment of Everett Cunningham as chief commercial officer (CCO), effective June 10. Cunningham comes to Illumina from Exact Sciences, where he oversaw marketing, sales, and customer service as CCO. He has also held senior leadership roles at Quest Diagnostics, GE Healthcare, and Pfizer.

Quantum-Si: Chuck Kummeth

Quantum-Si has appointed Charles "Chuck" Kummeth as independent chairman of the board. Kummeth most recently served as president and CEO of Bio-Techne. Prior to Bio-Techne, he was president of mass spectrometry and chromatography and president of the laboratory consumables division at Thermo Fisher Scientific. Earlier, Kummeth held various roles over 24 years at 3M, including as VP of the company's medical division. He holds a BS in electrical engineering from the University of North Dakota, an MS in computer science from the University of St. Thomas, and an MBS from the Carlson School of Business at the University of Minnesota. Kummeth also serves on the boards of Gentherm, PerkinElmer, and Orthofix.

Johns Hopkins University: Jane Carlton

Jane Carlton has been named Bloomberg Distinguished Professor of Malaria Genomics and Global Public Health. She is the director of the Johns Hopkins Malaria Research Institute, which she joined last summer. Previously, she was a professor of biology and faculty director of genomic sequencing at the Center for Genomics and Systems Biology at New York University. She holds a BS in biological sciences and genetics and a PhD in genetics from the University of Edinburgh.

23andMe: Kathy Hibbs

Kathy Hibbs has retired as chief administrative officer of 23andMe. Hibbs will remain a consultant to the company to support the transition of legal and regulatory related work.